How big is the Oral Transmucosal Drugs Market?

The Oral Transmucosal Drugs Market size is expected to reach USD 16.57 billion in 2024 and grow at a CAGR of 6.75% to reach USD 22.97 billion by 2029. Read More

What is the current Oral Transmucosal Drugs Market size?

In 2024, the Oral Transmucosal Drugs Market size is expected to reach USD 16.57 billion. Read More

Who are the key players in Oral Transmucosal Drugs Market?

ZIM Laboratories Limited, Aquestive Therapeutics, Inc., IntelGenx Corp., Novartis AG and Sunovion Pharmaceuticals, Inc. are the major companies operating in the Oral Transmucosal Drugs Market. Read More

Which is the fastest growing region in Oral Transmucosal Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Oral Transmucosal Drugs Market?

In 2024, the North America accounts for the largest market share in Oral Transmucosal Drugs Market. Read More

What years does this Oral Transmucosal Drugs Market cover, and what was the market size in 2023?

In 2023, the Oral Transmucosal Drugs Market size was estimated at USD 15.45 billion. The report covers the Oral Transmucosal Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oral Transmucosal Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Oral Transmucosal DrugsCompanies

This report lists the top Oral Transmucosal Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Oral Transmucosal Drugs industry.